Generic Name : Gefitinib Pronunciation : geh-FIT-in-ib Therapeutic Classification : Chemotherapy ICD Code : Y43.3
Therapeutic Classification : Chemotherapy Trade Name(s):
India- Chemofit, Gefitec, Gefitero, Gefonib, Geftib, Geftilon, Geftinat.
International- Iressa. Why it is prescribed (Indications) :
This medication is a chemotherapy agent, prescribed for non-small cell lung cancer. It blocks the action of a certain substance that may be needed for cancer cell multiplication. When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken :
Adult- PO- The recommended daily dose is one 250 mg. How it should be taken :
It comes as a tablet to take by mouth, with or without food. Warnings and Precautions :
* Caution should be exercised in patients with history of lung disease, heart, kidney, or liver problems; any allergy, who are taking other medications, during pregnancy and breastfeeding.
* It may cause changes in vision, do not drive a car or operate machinery while taking this medication. Side Effects :
Diarrhea, rash, pimples, dry skin, nausea, vomiting, itching, loss of appetite, weakness and weight loss.
* Avoid excess dosage. Storage Conditions :
Store it at controlled room temperature (20-25°C).
Comment & Contribute
Ask an Expert